TG Therapeutics Investigational Trial Site

Salt Lake City, Utah 84106

1 studies enrolling now · 2 studies all time

What they study most

Chronic Lymphocytic Leukemia, Relapsing Multiple Sclerosis, Small Lymphocytic Lymphoma

Studies at this site

• Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab — Recruiting now
• Study to Assess the Efficacy and Safety of Ublituximab in Combination With Umbralisib and Venetoclax Compared to Ublituximab in Combination With Umbralisib in Subjects With CLL (ULTRA-V) — Stopped early